SOPHiA GENETICS SA (SOPH), an AI-driven precision medicine company, on Tuesday announced pricing of an underwritten public offering.
The company is issuing 6,508,650 ordinary shares at a public offering price of $4.75 per share.
Additionally, the company is offering underwriters a 30-day option to purchase up to 10,526,000 ordinary shares at the public offering price.
The gross proceeds from the offering are estimated to be $50 million.
The offering is expected to close on June 18, 2026.
The lead book-running manager for the offering is TD Cowen.
SOPH closed Tuesday at $4.93, down 1.60%.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.